Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022;24(1):71–164.

Article  PubMed  Google Scholar 

Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2019;140(8):e382–482.

PubMed  Google Scholar 

Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001–6.

Article  PubMed  Google Scholar 

Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33(4):414–9.

Article  PubMed  Google Scholar 

Joy PS, Kumar G, Poole JE, London B, Olshansky B. Cardiac implantable electronic device infections: who is at greatest risk? Heart Rhythm. 2017;14(6):839–45.

Article  PubMed  Google Scholar 

Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17(5):767–77.

Article  PubMed  Google Scholar 

Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553–61.

Article  PubMed  Google Scholar 

Rennert-May E, Chew D, Lu S, Chu A, Kuriachan V, Somayaji R. Epidemiology of cardiac implantable electronic device infections in the United States: a population-based cohort study. Heart Rhythm. 2020;17(7):1125–31.

Article  PubMed  Google Scholar 

Birnie DH, Wang J, Alings M, Philippon F, Parkash R, Manlucu J, et al. Risk factors for infections involving cardiac implanted electronic devices. J Am Coll Cardiol. 2019;74(23):2845–54.

Article  PubMed  Google Scholar 

Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.

Article  PubMed  Google Scholar 

Krahn AD, Lee DS, Birnie D, Healey JS, Crystal E, Dorian P, et al. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4(2):136–42.

Article  PubMed  Google Scholar 

Olsen T, Jørgensen OD, Nielsen JC, Thøgersen AM, Philbert BT, Johansen JB. Incidence of device-related infection in 97 750 patients: clinical data fromthe complete Danish device-cohort (1982–2018). Eur Heart J. 2019;40(23):1862–9.

Article  PubMed  PubMed Central  Google Scholar 

Baldauf B, Lau EW, Giaccardi M, Bonnemeier H. An unusual cause of inappropriate shocks delivered by an implantable cardioverter defibrillator. BMC Cardiovasc Disord. 2024;24(1):380.

Article  PubMed  PubMed Central  Google Scholar 

Sohail MR, Eby EL, Ryan MP, Gunnarsson C, Wright LA, Greenspon AJ. Incidence, treatment intensity, and incremental annual expenditures for patients experiencing a cardiac implantable electronic device infection: evidence from a large us payer database 1-year post implantation. Circ Arrhythm Electrophysiol. 2016;9(8):e003929.

Article  PubMed  Google Scholar 

Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171(20):1821–8.

Article  PubMed  Google Scholar 

Greenspon AJ, Eby EL, Petrilla AA, Sohail MR. Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol. 2018;41(5):495–503.

Article  PubMed  Google Scholar 

Ludwig S, Theis C, Brown B, Witthohn A, Lux W, Goette A. Incidence and costs of cardiac device infections: retrospective analysis using German health claims data. J Comp Eff Res. 2018;7(5):483–92.

Article  PubMed  Google Scholar 

Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18):1796–801.

Article  PubMed  Google Scholar 

de Oliveira JC, Martinelli M, Nishioka SA, Varejão T, Uipe D, Pedrosa AA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2(1):29–34.

Article  PubMed  Google Scholar 

Mittal S, Wilkoff BL, Kennergren C, Poole J, Corey R, Bracke F, et al. The world-wide randomized antibiotic envelope infection prevention (WRAP-IT) trial: long-term follow-up. Heart Rhythm. 2020;17(7):1115–22.

Article  PubMed  Google Scholar 

Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019;380(20):1895–905.

Article  CAS  PubMed  Google Scholar 

Ziacchi M, Biffi M, Iacopino S, di Silvestro M, Marchese P, Miscio F, et al. REducing INFectiOns thRough Cardiac device Envelope: insight from real world data The REINFORCE Project. Europace. 2023;25(11):euad224.

Article  PubMed  PubMed Central  Google Scholar 

Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia pacific Heart Rhythm Society (APHRS), the Latin American heart rhythm society (LAHRS), international society for cardiovascular infectious diseases (ISCVID) and the European society of clinical microbiology and infectious diseases (ESCMID) in collaboration with the European association for cardio-thoracic surgery (EACTS). Europace. 2020;22(4):515–49.

Article  PubMed  Google Scholar 

Baddour LM, Esquer Garrigos Z, Rizwan Sohail M, Havers-Borgersen E, Krahn AD, Chu VH, et al. Update on cardiovascular implantable electronic device infections and their prevention, diagnosis, and management: a scientific statement from the american heart association: endorsed by the international society for cardiovascular infectious diseases. Circulation. 2024;149(2):e201–16.

Article  PubMed  Google Scholar 

Vonthein R, Baldauf B, Borov S, Lau EW, Giaccardi M, Cemin R, et al. The European TauroPace™ registry. Methods Protoc. 2023;6(5):86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas LLM, Sturk A, Büller HR. The in-vitro inactivation of endotoxins by taurolin. In: Brückner WL, Pfirrmann RW, editors. Taurolin: a new concept for antimicrobial chemotherapy of surgical infection. München: Urban and Schwarzenberg; 1985. p. 78–81.

Google Scholar 

Stendel R, Scheurer L, Schlatterer K, Stalder U, Pfirrmann RW, Fiss I, et al. Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients. Clin Pharmacokinet. 2007;46(6):513–24.

Article  CAS  PubMed  Google Scholar 

Gorman SP, McCafferty DF, Woolfson AD, Jones DS. Electron and light microscopic observations of bacterial cell surface effects due to taurolidine treatment. Lett Appl Microbiol. 1987;4(5):103–9.

Article  Google Scholar 

Blenkharn JI. The antimicrobial activity of taurolin®—a possible additive for parenteral nutrition solutions. Clin Nutr. 1987;6(1):35–8.

Article  CAS  Google Scholar 

Myers E, Allwood MC, Gidley MJ, Sanders JK. The relationship between structure and activity of taurolin. J Appl Bacteriol. 1980;48(1):89–96.

Article  CAS  PubMed  Google Scholar 

Erb F, Imbenotte M, Huvenne JP, Vankemmel M, Scherpereel P, Pfirrmann RW. Structural investigation of a new organic antiseptic: taurolidine. Eur J Drug Metab Pharmacokinet. 1983;8(2):163–73.

Article  CAS  Google Scholar 

Weichsel J, Baldauf B, Bonnemeier H, Lau EW, Dittrich S, Cesnjevar R. Eradication of ventricular assist device driveline infection in paediatric patients with taurolidine. J Cardiovasc Dev Dis. 2022;9(1):18.

PubMed  PubMed Central  Google Scholar 

Giaccardi M, Baldauf B, Lau EW, Borov S, Bonnemeier H. Salvage of cardiac implantable electronic device pocket infection with skin erosion in frail 92-year-old. J Cardiovasc Dev Dis. 2022;9(3):81.

PubMed  PubMed Central